FDA WARNING LETTER – Shilpa Medicare Limited

Shilpa Medicare Limited FDA Warning Letter 2020 Delivery Method:VIA UPSProduct:Drugs Recipient:Mr. Vishnukant Chaturbhuj BhutadaManaging DirectorShilpa Medicare Limited #12-6-214/A1 Hyderabad RoadRaichur 584135 KarnatakaIndiaIssuing Office:Center for Drug Evaluation and Research | CDER United States Warning Letter 320-21-01 October 9, 2020 Dear Mr. Bhutada: The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility at Shilpa Medicare Limited, […]

FDA WARNING LETTER – Shilpa Medicare Limited Read More »

SOP For Vendor Management

The manufacturer or supplier who is supplying the material in routine and registered for the supply of specific material after the approval process considered as an approved vendor. Vendor management consists of the Identification, Qualification, Requalification, management of changes at the vendor site, Vendor Audit, Technical Agreement, Deregistration Process, etc. Vendor Management   PURPOSE: The

SOP For Vendor Management Read More »

SOP on Change Control

Mastering Change Control in the Pharmaceutical Industry: A Guide to Quality and Compliance Navigate the intricacies of change control with this comprehensive guide! Ensuring the safety, efficacy, and quality of pharmaceutical products hinges on meticulous control over changes. This SOP dives into the essential steps and considerations for implementing an effective change control system in

SOP on Change Control Read More »